SU
Sudeep Pharma Ltd (SUDEEPPHRM)
₹1,326.70
Mkt cap
₹15,014 Cr
P/E ratio
82.20
P/B
16.97
Div yield
0.11%
ROE
25.20%
ROCE
28.20%
EPS (TTM)
₹16.14
Book value
₹78
52W range
530–1,335
Sector
Healthcare
Price history
Previous close
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries. [1]
NSE SUDEEPPHRMBSE 544619
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthHigh
TechnicalsNeutral
52-week range
−0.62% from high₹1,327
₹530+150.32% from low₹1,335
Current
₹1,326.70
Prev close
₹1,335.00
Day
−0.62%
Price performance
1D
−0.62%
1W
+9.67%
1M
+38.55%
3M
+78.90%
6M
+127.17%
1Y
—
YTD
+122.30%
Financials
Revenue, profit & margin
P/E ratio
82.2×
SUDEEPPHRM is 142% above the sector median of 34.0×
SUDEEPPHRM82.2×
Sector median34.0×
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 116 | 158 | 125 | 163 | 172 | 182 | 158 | |
| Expenses | 85 | 76 | 99 | 81 | 107 | 112 | 120 | 103 | |
| Operating Profit | 63 | 39 | 59 | 44 | 55 | 60 | 63 | 55 | |
| OPM % | 43% | 34% | 37% | 35% | 34% | 35% | 34% | 35% | |
| Other Income | 2 | 2 | 4 | 5 | 10 | 7 | 6 | 5 | |
| Interest | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | |
| Profit before tax | 62 | 38 | 58 | 44 | 60 | 62 | 63 | 54 | |
| Tax % | 21% | 24% | 24% | 29% | 21% | 23% | 23% | 25% | |
| Net Profit | 49 | 29 | 44 | 31 | 47 | 48 | 49 | 41 | |
| EPS in Rs | 128.13 | 2.95 | 4.54 | 3.17 | 4.71 | 4.20 | 4.33 | 3.59 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +10.00% · closed higher next day 1 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 4 Aug '26◦ |
| Earnings day | +10.00% |
| +1 day | +11.74% |
| +5 days | +26.61% |
| +15 days | +29.51% |
| +30 days | — |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202676.16%Promoter
Promoters76.16%
FIIs1.81%0.26
DIIs15.64%2.47
Public6.39%2.21
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | ₹1,899.00 | 36.07 | 4,55,634 | 0.84% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| DIVISLAB | ₹9,100.00 | 81.09 | 2,41,576 | 0.33% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| TORNTPHARM | ₹4,857.00 | 82.80 | 1,84,745 | 0.78% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| CIPLA | ₹1,385.00 | 31.26 | 1,11,888 | 0.94% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| ZYDUSLIFE | ₹1,120.00 | 22.95 | 1,11,720 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| LAURUSLABS | ₹1,840.00 | 90.93 | 99,417 | 0.11% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| LUPIN | ₹2,110.00 | 16.20 | 96,483 | 0.85% | 1,417 | +16.08% | 8,277 | +32.04% | 29.93% |
| SUDEEPPHRM | ₹1,329.30 | 82.21 | 15,014 | 0.11% | 41 | +31.61% | 158 | +26.70% | 28.18% |
| Median: 158 Co. | ₹421.50 | 33.96 | 2,277 | 0.08% | 13 | +30.25% | 164 | +18.67% | 14.96% |
Filings
Annual reports1
Concall transcripts12
Credit ratings2
Announcements5
Announcement under Regulation 30 (LODR)-Earnings Call Transcript 11 Aug - Submission of Earnings Call Transcript for the call held on 05.08.2026General Update 6 Aug - Corrected AGM attendees to 44 instead of 45 for 4 August 2026 meeting.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 5 Aug - Audio recording of Sudeep Pharma’s 5 August 2026 earnings call uploaded online.Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 5 AugAnnouncement under Regulation 30 (LODR)-Newspaper Publication 5 Aug - Submission of newspaper publication of Financials as on 30.06.2026